X4 Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focusing on the development of innovative therapeutics for patients with rare genetic diseases and cancer. With a strong pipeline of novel drug candidates and a commitment to scientific advancement, X4 Pharmaceuticals aims to make a significant impact in improving patient outcomes and addressing unmet medical needs.
